You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Data privacy firm Oasis Labs will offer a consumer-controlled data management app to customers of the DNA testing company, which was cofounded by George Church.
Under the deal, Shivom will offer Family Care Path's MyLegacy web-based clinical decision support application through its online app marketplace.
After giving up on the cryptocurrency idea, LunaDNA looks to "invert the research equation" by letting patients control and sell their genomic and health information.
Blockchain-based startup EncrypGen will take advantage of Murrieta Genomics' sequencing lab and business services to market its Gene-Chain platform for data sharing.
Shivom and Lifebit will offer an artificial intelligence-based platform for identifying the right patients for enrollment in clinical trials.
The startup plans to use blockchain to enable genomic data sharing and will partner with Veritas to gain access to its open-source software platform.
The year-old German company wants to help the healthcare industry decentralize genomic data with its platform for potentially billions of people worldwide.
Israeli firm DNATix recently claimed not only the transfer of a genetic sequence using blockchain technology, but the transfer of a complete Y chromosome.
The company intends to use the proceeds for, among other things, investigating the use of blockchain technology in medicine and biotechnology.
Nonprofit eMQT will use Shivom's decentralized blockchain platform to store and share genomic data of sickle-cell diseases in underserved regions.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.